Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Severin Schwan, Bruno Gehrig, Lodewijk de Vink

Premium

Roche has proposed adding company CEO Severin Schwan to its board of directors, and has said that two members of its board, Bruno Gehrig and Lodewijk de Vink, will not stand for re-election to the board.

Roche also said that the following current board members will be proposed for another term: Andreas Oeri; Pius Baschera; Paul Bulcke; William Burns; Christoph Franz; DeAnne Julius; Arthur Levinson; Peter Voser; and Beatrice Weder di Mauro.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.